En Es

Industry News

AI in Radiology Market Driven by Growing Adoption of Machine Learning Tools in Broad Spectrum of Imaging Applications

By Medimaging International staff writers
10 Nov 2021


Artificial intelligence (AI) tools and technologies have been making enormous impacts on various aspects of healthcare. The use of AI algorithms in medical image analysis field has made astounding progress. Particularly deep learning has made incessant inroads in radiology practice. The major consumer proposition for companies in the AI in radiology market stems from the exceptional capabilities of AI tools in recognizing complex patterns in the imaging data.

These are the latest findings of Transparency Market Research (Albany NY, USA), a next-generation market intelligence provider.

The exponential rise of clinical, molecular, imaging, and genomic data has extended the canvas for the need for utilization of advanced IT and data processing tools for assessments of radiographic characteristics, and enrich the work of radiologists. As a result, radiomics has made striking strides in recent years. The utilization of AI in radiology continues to expand, as is evident in the rise in the growing adoption of machine learning tools in broad spectrum of imaging applications, driving the AI in radiology market. Some of the key applications of AI in imaging are risk assessment, diagnosis, identification, prognosis, evaluation of risk of reoccurrence, and therapy response. Several clinically useful AI tools have been developed to meet these applications in AI in radiology market.

One of the key areas with massive potential revenues is oncology. Specifically, AI algorithms are used in a number of thoracic imaging tasks including such as lung nodules assessment for identifying whether these are benign or malignant, pneumonia detection, or estimation of diffuse lung diseases. The past few years have seen rapid technological advancements in deep learning, raising the standard of AI, which has expanded the horizon of the AI in radiology market. A number of anomalies have been found to open to detection for radiologists. Deep learning integrated with magnetic resonance imaging (MRI) has been found to make time-based assessment of the histological analysis of breast cancer. Images from other modalities are also open to a reliable scrutiny by AI methods; examples are computed tomography (CT) and positron emission tomography (PET). A case in point is the growing clinical potential of use of ML tools in pancreatic cancer analysis in CT and MRI.

Some of the end-use areas in the AI in radiology market are abdominal and pelvic imaging, colonoscopy, mammography, and brain imaging. The areas of applications continue to expand with the growing awareness about the unique capabilities of AI in radiomics. A case in point is the emerging prospects in chest computed radiography. The use cases of AI in DNA and RNA sequencing is anticipated to unlock an incredible avenue for players in the AI in the radiology market. AI tools have become a friend for radiologists, and in the near future will increasingly complement diagnosis and clinical care.

Players in the AI in radiology market are constantly striving to offer solutions that bridge the gap between training and applications in real-world populations. Hospitals also simultaneously need to upskill their healthcare staff in using complex AI systems. In effect, this is one of the key focus areas for AI tools developers in the AI in radiology market to reduce the chances of errors and prevent algorithmic biases. Another area that is replete with opportunities is ethical aspects of AI. Human designers and operators should work collaboratively to develop next-gen AI for radiology applications. The aspect should be at the crux of new product development, opines experts, and the factor will also massively shape the competitive dynamics of the AI in radiology market.

Geographically, North America is a highly lucrative AI in radiology market. Its growth has been fueled by massive advancements in deep learning tools. The healthcare industry has been increasingly benefitted from the growing practical implications of AI in radiomics. Asia Pacific is being viewed as an emerging AI in radiology market in recent years. The growing technical expertise of leveraging AI for patient well-being will propel the growth of this regional market, going forward.

Related Links:
Transparency Market Research 

E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

18 Jan 2022
Global Coagulation Analyzers Market Driven by Growing Awareness About Timely Diagnosis of Blood Clots
The global coagulation analyzers market is expected to reach USD 11.7 billion by 2028, driven by the increasing understanding of blood clots and the fact that they can be avoided with early detection.
Read More
17 Jan 2022
Mobile C-Arms Market to Surpass USD 1.6 Billion in 2027 Due to Growing Preference for Minimally Invasive Surgeries
The global mobile C-arms market is expected to grow at a CAGR of 5.2% from USD 1.07 billion in 2019 to USD 1.61 billion in 2027, driven primarily by an increase in the global geriatric population, rising burden of chronic and acute diseases across the world, increasing volumes of orthopedic, cardiac, neurological, and oncological surgical procedures, and growing preference for minimally invasive surgeries.
Read More
14 Jan 2022
Medlab Middle East to Reveal Latest Innovations and Technologies in Mobile Labs for COVID-19 Testing
The latest technology and innovation in the global fight against COVID-19 and beyond will be on show at the next edition of Medlab Middle East when it returns to the Dubai World Trade Center from 24-27 January 2022 with mobile molecular testing and diagnosis stations, or ‘laboratories on wheels’, from companies such as Seegene, Inc. (Seoul, Korea) taking center stage.
Read More
13 Jan 2022
Global Coagulometers Market to Be Driven by Rising Prevalence of Blood Disorders
The global coagulometers market is being driven by a rise in the incidence and prevalence of blood disorders such as hemophilia that is fueling the demand for more diagnostic tools.
Read More
11 Jan 2022
Medlab Middle East to Return as Standalone Event in 2023
Informa Markets (London, UK), organizers of Medlab Middle East, have announced that the MENA region’s leading exhibition for the laboratory industry will return to a standalone event in 2023.
Read More
11 Jan 2022
J&J Medical Devices Companies Partners with Microsoft to Further Enable its Digital Surgery Solutions
The Johnson & Johnson Medical Devices Companies (JJMDC; New Brunswick, NJ, USA) will collaborate with Microsoft (Redmond, Wash., USA; www.microsoft.com) to further enable and expand JJMDC’s secure and compliant digital surgery ecosystem.
Read More
10 Jan 2022
ICU Medical Completes Acquisition of Smiths Medical to Create Leading Infusion Therapy Company
ICU Medical Inc. (San Clemente, CA, USA) has completed its acquisition of Smiths Medical (Minneapolis, MN, USA) from Smiths Group plc that includes syringe and ambulatory infusion devices, vascular access, and vital care products. When combined with ICU Medical's existing businesses, the combined companies create a leading infusion therapy company.
Read More
05 Jan 2022
Global Portable Ultrasound Scanner Market to Be Driven by Rising Trauma and Accident Cases
The global portable ultrasound scanner market is being driven by an increase in targeted illnesses, rise in trauma & accident cases, surge in demand for less invasive operations, and the emergence of a senior population at a high risk of diseases.
Read More
04 Jan 2022
Global Mammography Workstations Market to Surpass USD 0.19 Billion in 2028 Due to Increasing Prevalence of Breast Cancer
The global mammography workstations market is projected to grow at a CAGR of 6.8% from about USD 0.12 billion in 2020 to more than USD 0.19 billion in 2028, led by increasing prevalence of breast cancer across the world, growing need for early breast cancer diagnosis and treatment, rise in government initiatives to spread breast cancer awareness, and rapid adoption of advanced mammography workstations in hospitals, clinics, and breast care centers.
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions